Fujifilm, Fox Chase Cancer Center Sign R&D Agreement for Endoscopy Products

Fujifilm Holdings Corp., based in Valhalla, N.Y., signed a five-year comprehensive joint research and development agreement on endoscopy-related products with Fox Chase Cancer Center in Philadelphia, according to a Fujifilm news release.

Fujifilm has entered into the research and development partnership with FCCC to reinforce its efforts to develop diagnostic and therapeutic instruments that meet and anticipate the North American clinical needs in the endoscopy suite and the operating room, according to the release.

"As one of the leading cancer research and treatment facilities in the United States, FCCC provides exceptional knowledge and expertise in the fields of gastrointestinal endoscopy, pulmonary endoscopy and endoscopic surgery," Sumito Yamada, general manager, FUJIFILM Medical Systems Research and Development Center, said in the release. "We believe that this expertise, combined with Fujifilm's extensive research and development organization will allow us to support medical practitioners' basic research in therapeutic endoscopy, SPS and NOTES as a way of contributing to future product development for the actualization of next-generation options in minimally invasive treatment."

Under the agreement, Fujifilm with provided new endoscopy equipment and resources to the cancer center's endoscopy laboratory, and FCCC physicians will offer the company their expertise in developing new endoscopes and other medical devices, according to the release.

Fujifilm currently markets a full-line of distinctive endoscopic products, including a trans-nasal gastroscope which reduces the need for sedatives and Double Balloon Endoscopy, the world's first endoscope platform capable of visualization and treatment of the entire small bowel, according to the release.

Read the release on the Fujifilm-Fox Chase research and development partnership.